Table 4 Genotype frequencies of four polymorphisms in ONFH patients (total, idiopathic and secondary) and controls
Genotype | Controls N=100 | Patients | ||
|---|---|---|---|---|
Total N=68 | Idiopathic n=45 | Secondary n=23 | ||
Factor V Leiden | ||||
GA | 3(3%) | 3(4,41%) | 3(6,67%) | 0 |
GG | 97(97%) | 65(95,59%) | 42(93,33%) | 23(100%) |
Prothrombin | ||||
GA | 2(2%) | 1(1,47%) | 0 | 1(4,35%) |
GG | 98(98%) | 67(98,53%) | 45(100%) | 22(95,65%) |
MTHFR | ||||
TT | 7(7%) | 4(5,88%) | 4(8,89%) | 0 |
CT | 42(42%) | 35(51,47%) | 23(51,11%) | 12(52,17%) |
CC | 51(51%) | 29(42,65%) | 18(40%) | 11(47,83%) |
TPA | ||||
DD | 18(18%) | 13(19,12%) | 11(24,44%)a | 2(8,7%) |
ID | 37(37%) | 38(55,88%)b | 24(53,33%)c | 14(60,87%) |
II | 45(45%) | 17(25%) | 10(22,22%) | 7(30,43%) |